Hostname: page-component-77c89778f8-vsgnj Total loading time: 0 Render date: 2024-07-17T13:05:06.288Z Has data issue: false hasContentIssue false

Report of the Massachusetts Task Force on Organ Transplantation

Published online by Cambridge University Press:  28 April 2021

Extract

The Task Force on Organ Transplantation was announced on September 26, 1983 by the Secretary of Human Services and the Commissioner of Public Health, and charged with “the development of standards and processes for evaluating the use of organ transplantation” in Massachusetts. It was asked to

  • make recommendations concerning how organ transplantation should he introduced and financed, including mechanisms to assure equality of access;

  • determine what priority should be placed by the state on extreme and expensive medical interventions;

  • determine what criteria should be used in patient selection; and

  • determine how and by whom decisions concerning transplantation availability and patient selection criteria should be made.

Type
Article
Copyright
© 1985 American Society of Law, Medicine & Ethics

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, Securing Access to Health Care: The Ethical Implications of Differences in the Availability of Health Services (U.S. Gov't Printing Ofc., Washington, D.C.) (Vol. 1 1983) at 5 [hereinafter referred to as Securing Access].Google Scholar
Final Report of the Task Force on Liver Transplantation in Massachusetts (Fineberg Report) (May 1983) at 40.Google Scholar
Securing Access, supra note 1, at 25.Google Scholar
Coordinating Council, End Stage Renal Disease Network #28, Annual Report to the Secretary of Health and Human Services for Calendar Year 1982 (July 1, 1983).Google Scholar
Krakauer, H., The Recent U.S. Experience in the Treatment of End-Stage Renal Disease by Dialysis and Transplantation, New England Journal of Medicine 308(26): 1558–63 (June 30, 1983).Google ScholarPubMed
Personal communication with N.L. Tilney.Google Scholar
Griepp, R.N., A Decade of Human Heart Transplantation, Transplantation Proceedings 9: 265–91 (1979).Google Scholar
Shumway, N.E., Cardiac Replacement in Perspective, Heart Transplantation 3: 35 (1983).Google Scholar
Shumway, N.E., Recent Advances in Cardiac Transplantation, Transplantation Proceedings 15: 1221–24 (1983).Google Scholar
Thompson, M.E., Selection of Candidates for Cardiac Transplantation, Heart Transplantation 3: 6569 (1983).Google Scholar
Pennock, et al. , Cardiac Transplantation in Perspective for the Future: Survival, Complications, Rehabilitation and Cost, Journal of Thoracic and Cardiovascular Surgery 83: 168–77 (1982).Google ScholarPubMed
Reitz, B.A. Stinson, E.B., Cardiac Transplantation 1982, Journal of the American Medical Association 248(10): 1225–27 (September 10, 1982).Google ScholarPubMed
Cardiac Homotransplantation, Current Problems in Surgery, 16: 3 (1979).Google Scholar
Reitz, B.A., Heart-Lung Transplantation: A Review, Heart Transplantation 1: 8 (1982).Google Scholar
Moore, F.D., Experimental Whole Organ Transplantation of the Liver and Spleen, Annals of Surgery 152: 374–87 (1960).Google Scholar
Calne, R., Liver Transplantation (Grune & Stratton, New York, N.Y.) (1983).Google Scholar
Public Health Service, Assessment of Liver Transplantation (U.S. Gov't Printing Ofc., Washington, D.C.) (1983).Google Scholar
Starzl, T., Evolution of Liver Transplantation, Hepatology 2: 614–36 (1982).Google ScholarPubMed
Myers, B.D., Cyclosporine-Associated Chronic Nephropathy, New England Journal of Medicine 311(11): 699705 (September 13, 1984).Google ScholarPubMed
Annas, G.J. Glantz, L.H. Katz, B., The Rights of Doctors, Nurses, and Allied Health Professionals (Ballinger Books, Cambridge, Mass.) (1981) at 224–25.Google Scholar
Commonwealth v. Golston, 366 N.E.2d 744 (Mass. 1977), cert, denied, 434 U.S. 1039 (1978). See President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, Defining Death (U.S. Gov't Printing Ofc., Washington, D. C.) (1981) at 136–38.Google Scholar
Annas, G.J., Life, Liberty, and the Pursuit of Organ Sales, Hastings Center Report 14(1): 2223 (February 1984).Google ScholarPubMed
Much of this section relies on ideas in or derived from the work of Professor Guido Calabresi of Yale Law School, especially from Calabresi, G. Bobbitt, P., Tragic Choices (Norton, New York, N.Y.) (1978).Google Scholar
Fletcher, J., Our Shameful Waste of Human Tissue, in The Religious Situation (Cutler, D. R., ed.) (Beacon Press, Boston, Mass.) (1969) at 223–52.Google Scholar
Fox, R. Swazey, J., The Courage to Fail (University of Chicago Press, Chicago, Ill.) (1974) at 232.Google Scholar
Sanders, D. Dukeminier, J., Medical Advance and Legal Lag: Hemodialysis and Kidney Transplantation, UCLA Law Review 15(1): 15 (1968).Google Scholar
Rettig, R.A., The Policy Debate on Patient Care Financing for Victims of End-Stage Renal Disease, Law & Contemporary Problems 40(4): 40 (Autumn 1976).Google ScholarPubMed
Tragic Choices, supra note 23.Google Scholar
Securing Access, supra note 1, at 25.Google Scholar
Tragic Choices, supra note 23.Google Scholar
Bayer, R., Justice and Health Care in an Era of Cost Containment: Allocating Scarce Medical Resources, Social Responsibility 9: 3752 (1984). See Annas G.J., Allocation of Artificial Hearts in the Year 2002: Minerva v. National Health Agency, American Journal of Law & Medicine 3(1): 59–76 (Spring 1977).Google Scholar
Commentary: UK's Poor Record in Treatment of Renal Failure, Lancet, p. 53 (July 7 1984).Google Scholar
A 1969 study of the criteria employed by kidney dialysis centers in the United States found that the eight most frequently employed criteria were: (1) willingness to cooperate in treatment regimen (86 percent); (2) medical suitability (79 percent); (3) absence of other disabling disease (69 percent); (4) intelligence to understand treatment (34 percent), (5) likelihood of vocational rehabilitation (32 percent); (6) age (20 percent); (7) primacy of application for available vacancy (26 percent); and (8) psychiatric evaluation (25 percent). Fox & Swazey, supra note 25, at 230. The family question, as put to candidates at Stanford's heart transplantation center has been, “Does the patient have a strong supportive family willing and able to withstand the apprehension, anxiety, fear, waiting, fatigue, separation, euphoria, disappointment, and grief that the different phases of cardiac transplantation entail? Does the family have enough strength to provide continuing support to the patient as well as to manage the stresses of cardiac transplantation themselves?” Id. at 310–11.Google Scholar
Most, but not all, liver transplant programs exclude active alcoholics from consideration for liver transplantation The Boston Center for Liver Transplantation, for example, excludes alcoholics who have not abstained for less than two years, and more generally excludes “active drug or alcohol” users. The Brigham and Women's Hospital's Guidelines for Cardiac Transplantation are somewhat less explicit, asking referring physicians to consider “a history of alcohol or drug abuse, or mental illness that would complicate post-transplantation followup” as a “contraindication to cardiac transplantation.” The Task Force concluded that blanket exclusions, like that of the Liver Center, are arbitrary and tend to reinforce negative and destructive societal stereotypes. Accordingly, such individuals should not be per se excluded from screening if they want a transplant. On the other hand, it is reasonable and proper to consider the impact of the patient's substance abuse or mental illness on the probability of successfully following an immunosuppression regimen and being physically rehabilitated following transplant. Although such a judgment will also have large subjective elements, it is here, rather than on the disease of substance abuse itself, that the decision should focus.Google Scholar
Evans, R.W., Health Care Technology and the Inevitability of Resource Allocation and Rationing Decisions, Part II, Journal of the American Medical Association 249(16): 2208–17 (April 22/29, 1983).Google ScholarPubMed
The New England Organ Bank is in the process of changing its policy, but the following summarizes what it was. One of the two kidneys goes to the regional center that covers the hospital that procured it and the kidney is used at the hospital's discretion. The other is distributed on the basis of matching. Kidney matching is generally done on the basis of tissue compatibility to minimize the probability of rejection. Most importantly, the recipient must be crossmatch negative; i.e., there must not be a reaction when the recipient's blood is mixed with the white blood cells of the donor. If there is, there is likely to be a severe and early rejection of the kidney. If there is not, a patient in immediate need of a kidney may obtain one on this basis alone.Google Scholar